Occurrence of cocaine in urine of substance-abuse treatment patients

Journal of Analytical Toxicology

Volumn 22, Issue 7, 1998, Pages 580-586

  Preston, Kenzie L ^a,b   Goldberger, Bruce A ^a,b   Cone, Edward J ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; COCAINE; METHADONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG HALF LIFE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METHADONE TREATMENT; QUANTITATIVE DIAGNOSIS; RACE DIFFERENCE; SEX DIFFERENCE; SUBSTANCE ABUSE; URINALYSIS;

EID: 0031756892     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.7.580     Document Type: Article

References (3)

1. S.-H. Li, C.N. Chiang, B.C. Tai, C.K. Marschke, and R.L. Hawks. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use. Psychopharmacol. Bull. 31(4): 671-678 (1995).
2. S.L. Satel and T.R. Kosten. Designing drug efficacy trials in the treatment of cocaine abuse. J. Nerv. Ment. Dis. 179(2): 89-96 (1991).
3. Mandatory guidelines for Federal workplace drug testing programs. Fed. Regist. 53(69): 11970-11989 (1988).